Ranexa (ranolazine) for chronic angina

March 2006

You'll hear about Ranexa (ranolazine) for chronic angina. It's the first new pharmaceutical approach in over 20 years.

It's now approved in the U.S...later in Canada.

Conventional angina drugs reduce cardiac oxygen demand and may also increase blood flow.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

updated guidelines on menopausal treatment
Diabetes & Endocrinology Somavert is a new treatment option for acromegaly
Diabetes whether sulfonylureas increase mortality
Diabetes The new inhaled insulin, Exubera, is getting patients excited
Kidney Disease Even patients with SEVERE kidney disease seem to benefit from ACE inhibitors
Obesity & Weight Loss Acomplia and OTC orlistat for weight loss
Statins how to monitor for myopathy in patients taking statins
Canadians may not be able to get epinephrine inhalers (Primatene Mist, etc) from the U.S. anymore
Infectious Diseases possible liver toxicity in patients taking Ketek (telithromycin)
Infectious Diseases Health Canada is advising NOT to use Tequin (gatifloxacin) in patients with diabetes
Pertussis the need for timely pertussis vaccinations and booster doses
Cardiology LOW-dose vitamin K supplements to stabilize the effect of warfarin in certain patients
Cardiology Ranexa (ranolazine) for chronic angina
whether saw palmetto is effective for benign prostatic hyperplasia (BPH)
Some experts are now saying NOT to rely on soy protein or isoflavone supplements to prevent heart disease